BNGO
Bionano Genomics Inc
NASDAQ: BNGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.16
-2.52% today
Updated 2026-04-29
Market cap
$13.42M
P/E ratio
—
P/S ratio
0.47x
EPS (TTM)
$-4.85
Dividend yield
—
52W range
$1 – $6
Volume
0.3M
Bionano Genomics Inc (BNGO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-92.60%
Operating margin
-107.40%
ROE
-66.10%
ROA
-27.70%
Debt/equity
0.15x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $6.79M | $-18.85M | 47.32% | -311.63% | -277.48% |
| 2017 | $9.51M | $-23.37M | 36.55% | -244.28% | -245.82% |
| 2018 | $12.00M | $-18.50M | 27.41% | -170.12% | -154.13% |
| 2019 | $10.13M | $-29.84M | 33.18% | -255.44% | -294.55% |
| 2020 | $8.50M | $-41.14M | 32.61% | -453.39% | -483.78% |
| 2021 | $17.98M | $-72.44M | 21.54% | -428.79% | -402.84% |
| 2022 | $27.80M | $-132.60M | 21.38% | -473.70% | -476.93% |
| 2023 | $36.12M | $-232.49M | 26.49% | -595.98% | -643.74% |
| 2024 | $30.78M | $-112.02M | 1.23% | -337.87% | -363.98% |
| 2025 | $28.51M | $-26.39M | 21.95% | -116.95% | -92.59% |